ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 37 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $827,470 | +16.9% | 603,993 | +16.9% | 0.01% | +25.0% |
| Q2 2023 | $707,845 | -41.9% | 516,675 | 0.0% | 0.01% | -52.9% |
| Q1 2023 | $1,219,353 | +3.5% | 516,675 | 0.0% | 0.02% | +6.2% |
| Q4 2022 | $1,178,019 | -17.4% | 516,675 | 0.0% | 0.02% | -20.0% |
| Q3 2022 | $1,426,000 | +13.1% | 516,675 | 0.0% | 0.02% | +5.3% |
| Q2 2022 | $1,261,000 | -52.5% | 516,675 | -23.2% | 0.02% | -55.8% |
| Q1 2022 | $2,652,000 | -23.0% | 673,138 | -13.9% | 0.04% | -12.2% |
| Q4 2021 | $3,446,000 | -28.6% | 781,376 | 0.0% | 0.05% | -38.0% |
| Q3 2021 | $4,829,000 | -28.8% | 781,376 | -8.9% | 0.08% | -37.3% |
| Q2 2021 | $6,782,000 | -28.9% | 857,445 | -3.8% | 0.13% | -40.3% |
| Q1 2021 | $9,534,000 | – | 891,055 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 234,803 | $321,680 | 0.34% |
| BVF INC/IL | 4,326,710 | $5,927,593 | 0.16% |
| ARMISTICE CAPITAL, LLC | 1,824,000 | $2,498,880 | 0.04% |
| SVB FINANCIAL GROUP | 13,472 | $18,457 | 0.04% |
| JMAC ENTERPRISES LLC | 58,041 | $79,516 | 0.02% |
| Woodline Partners LP | 603,993 | $827,470 | 0.01% |
| INGALLS & SNYDER LLC | 51,849 | $71 | 0.00% |
| Ensign Peak Advisors, Inc | 443,001 | $606,911 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 27,150 | $37,196 | 0.00% |
| Curi RMB Capital, LLC | 10,000 | $13,700 | 0.00% |